TY  - JOUR
AU  - Masana, Lluis
AU  - Lopez Miranda, Jose
AU  - Civeira, Fernando
AU  - Reinares, Leonardo
AU  - Guijarro, Carlos
AU  - Plana, Nuria
AU  - Cuenca, Rafael
AU  - Sanchez, Demetrio
AU  - Hernandez, Jose Luis
AU  - Andres, Raimundo
AU  - Blanco, Agustin
AU  - Villamayor, Santiago
PY  - 2020
DO  - 10.1016/j.arteri.2020.02.003
UR  - http://hdl.handle.net/10668/15404
T2  - Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis
AB  - To describe the clinical characteristics, the reasons for initiating therapy, and the effects of treatment in the initial phase of evolocumab availability in lipid/internal medicine units in Spain. Retrospective, observational study, based on the...
LA  - en
PB  - Elsevier Espana
KW  - Arteriosclerotic cardiovascular disease
KW  - Enfermedad cardiovascular arteriosclerótica
KW  - Evolocumab
KW  - Familial hypercholesterolaemia
KW  - Hipercolesterolemia familiar
KW  - LDL-C
KW  - Lipid unit/internal medicine
KW  - Unidades de lípidos/medicina interna
KW  - cLDL
KW  - Aged
KW  - Antibodies, Monoclonal, Humanized
KW  - Anticholesteremic Agents
KW  - Atherosclerosis
KW  - Cholesterol, LDL
KW  - Ezetimibe
KW  - Female
KW  - Humans
KW  - Hydroxymethylglutaryl-CoA Reductase Inhibitors
KW  - Hyperlipoproteinemia Type II
KW  - Male
KW  - Middle Aged
KW  - Retrospective Studies
KW  - Spain
TI  - Clinical profile of patients treated with evolocumab in lipid/internal medicine units of Spain. Observational study (RETOSS-IMU).
T2  - Perfil clínico de los pacientes tratados con evolocumab en unidades de lípidos/medicina interna en España. Estudio observacional (RETOSS-IMU).
TY  - research article
VL  - 32
ER  -